PLoS ONE · 2020 · 10 citations · 42 references
Life SciencesImmunologyPharmacotherapyClinical ImmunologyImmunoregulationInflammationAntiretroviral TherapyAntiviral TherapyChronic InflammationHuman Immunodeficiency Virus PharmacotherapyImmunomodulatory DrugsInflammation In Infectious DiseaseAnti-inflammatory MechanismsAnti-inflammatory ResponseAnti-inflammatory TherapeuticsImmune Biomarker MonitoringImmune Cell ActivationImmune Reconstitution After Antiretroviral TherapyPharmacodynamics Of Antiretroviral TherapyProtease Inhibitor Resistance
OBJECTIVE: Optimization of antiretroviral therapy and anti-inflammatory treatments, such as statins, are among the strategies aimed at reducing metabolic disorders, inflammation and immune activation in people living with HIV (PLWH). We evaluated the potential benefit of combining both strategies. DESIGN: Forty-two PLWH aged ≥40 years receiving a protease inhibitor (PI)-based regimen were randomized (1:1) to switch from PI to Raltegravir (n = 20), or to remain on PI (n = 22). After 24 weeks, all patients received atorvastatin 20mg/day for 48 weeks. METHODS: We analyzed plasma inflammatory as well as T-cell maturation, activation, exhaustion and senescence markers at baseline, 24 and 72 weeks. RESULTS: Plasma inflammatory markers remained unchanged. Furthermore, no major changes on T-cell maturation subsets, immunoactivation, exhaustion or immunosenescence markers in both CD4 and CD8 T cell compartments were observed. Only a modest decrease in the frequency of CD38+ CD8 T cells and an increase in the frequency of CD28-CD57+ in both CD4 and CD8 T-cell compartments were noticed in the Raltegravir-switched group. CONCLUSIONS: The study combined antiretroviral switch to Raltegravir and Statin-based anti-inflammatory strategies to reduce inflammation and chronic immune activation in PLWH. Although this combination was safe and well tolerated, it had minimal impact on inflammatory and immunological markers. CLINICAL TRIALS REGISTRATION: NCT02577042.
42
J. Schouten, Ferdinand W.N.M. Wit, Ineke G. Stolte et al. · Clinical Infectious Diseases · 2014 · 774 citations · Full text
Jeffrey L. Lennox, Edwin DeJesus, Adriano Lazzarin et al. · The Lancet · 2009 · 620 citations